Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Mol Med ; 42(2): 926-934, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29767265

RESUMO

Intestinal ischemia and reperfusion (II/R) injury often triggers severe injury in remote organs, with the lungs being considered the main target. Excessive elevation of proinflammatory cytokines is a major contributor in the occurrence and development of II/R­induced acute lung injury (ALI). Therefore, the present study aimed to investigate whether blocking tumor necrosis factor­α (TNF­α) expression could protect the lungs from injury following II/R, and to explore the possible underlying mechanism involving interleukin­10 (IL­10). Briefly, II/R was induced in rats by 40 min occlusion of the superior mesenteric artery and celiac artery, followed by 8, 16 or 24 h of reperfusion. Subsequently, lentiviral vectors containing TNF­α short hairpin (sh)RNA were injected into the right lung tissues, in order to induce TNF­α knockdown. The severity of ALI was determined according to lung injury scores and lung edema (lung wet/dry weight ratio). The expression levels of TNF­α were analyzed by quantitative polymerase chain reaction (qPCR), western blotting and immunofluorescence (IF) staining. IL­10 expression, in response to TNF­α knockdown, was detected in lung tissues by qPCR and IF. The results detected marked inflammatory responses, and increased levels of lung wet/dry weight ratio and TNF­α expression, in the lungs of II/R rats. Conversely, treatment with TNF­α shRNA significantly alleviated the severity of ALI and upregulated the expression levels of IL­10 in lung tissues. These findings suggested that TNF­α RNA interference may exert a protective effect on II/R­induced ALI via the upregulation of IL­10. Therefore, TNF­α knockdown may be considered a potential strategy for the prevention or treatment of ALI induced by II/R in future clinical trials.


Assuntos
Lesão Pulmonar Aguda/terapia , Interleucina-10/genética , RNA Interferente Pequeno/uso terapêutico , Terapêutica com RNAi/métodos , Traumatismo por Reperfusão/terapia , Fator de Necrose Tumoral alfa/genética , Lesão Pulmonar Aguda/complicações , Lesão Pulmonar Aguda/genética , Lesão Pulmonar Aguda/patologia , Animais , Mucosa Intestinal/metabolismo , Intestinos/patologia , Pulmão/metabolismo , Pulmão/patologia , Masculino , RNA Interferente Pequeno/genética , Ratos , Ratos Sprague-Dawley , Traumatismo por Reperfusão/complicações , Traumatismo por Reperfusão/genética , Traumatismo por Reperfusão/patologia , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA